BPG is committed to discovery and dissemination of knowledge
Featured Articles
6/4/2021 1:56:09 PM | Browse: 33 | Download: 31
Publication Name World Journal of Diabetes
Manuscript ID 61327
Country/Territory Brazil
2020-12-02 14:27
Peer-Review Started
2020-12-02 14:29
To Make the First Decision
Return for Revision
2020-12-24 19:42
2020-12-29 15:14
Second Decision
2021-02-22 03:35
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-03-08 06:34
Articles in Press
2021-03-08 06:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-05-17 06:15
Typeset the Manuscript
2021-06-03 00:26
Publish the Manuscript Online
2021-06-04 13:47
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology and Metabolism
Manuscript Type Minireviews
Article Title Diabetes and inflammatory diseases: An overview from the perspective of Ca2+/3'-5'-cyclic adenosine monophosphate signalling
Manuscript Source Invited Manuscript
All Author List Leandro Bueno Bergantin
Funding Agency and Grant Number
Corresponding Author Leandro Bueno Bergantin, PhD, Professor, Department of Pharmacology, Universidade Federal de São Paulo, Rua Pedro de Toledo, 669–Vila Clementino, São Paulo 04039-032, Brazil. leanbio39@yahoo.com.br
Key Words Diabetes, cancer, hypertension, dementia; Ca2+/3'-5'-cyclic adenosine monophosphate signalling; Ca2+ channel blockers; Pharmacotherapy; Neurodegeneration; COVID-19
Core Tip There are several reviews in the literature about diabetes and inflammatory diseases. Nonetheless, to my knowledge, this is the first review which clearly discussed the role of Ca2+/3'-5'-cyclic adenosine monophosphate (cAMP) signalling in the link among diabetes and inflammatory diseases. This article also included a timeline of the major events in Ca2+/cAMP signalling field, and also discussed recent reports about the role of Ca2+ channel blockers for preventing Ca2+ signalling disruption due to coronavirus disease 2019 (COVID-19), including the correlation between COVID-19 and diabetes.
Publish Date 2021-06-04 13:47
Citation Bergantin LB. Diabetes and inflammatory diseases: An overview from the perspective of Ca2+/3'-5'-cyclic adenosine monophosphate signalling. World J Diabetes 2021; 12(6): 767-779
URL https://www.wjgnet.com/1948-9358/full/v12/i6/767.htm
DOI https://dx.doi.org/10.4239/wjd.v12.i6.767
Full Article (PDF) WJD-12-767.pdf
Full Article (Word) WJD-12-767.docx
Manuscript File #61327_Auto_Edited_LM-Webster J-Clear.docx
Answering Reviewers 61327-Answering reviewers.pdf
Audio Core Tip 61327-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 61327-Conflict-of-interest statement.pdf
Copyright License Agreement 61327-Copyright license agreement.pdf
Peer-review Report 61327-Peer-review(s).pdf
Scientific Misconduct Check 61327-Bing-Wang JL-1.jpg
Scientific Misconduct Check 61327-Bing-Fan JR-2.png
Scientific Misconduct Check 61327-Scientific misconduct check.pdf
Scientific Editor Work List 61327-Scientific editor work list.pdf